霉酚酸的药效学和药代动力学为合理的监测策略提供了依据。 - Suppr

Suppr

超能文献

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

作者信息

Shaw Leslie M, Korecka Magdalena, Venkataramanan Raman, Goldberg Lee, Bloom Roy, Brayman Kenneth L

机构信息

Department of Pathology & Laboratory Medicine, School of Pharmacy, University of Pittsburgh, PA 15261, USA.

出版信息

Am J Transplant. 2003 May;3(5):534-42. doi: 10.1034/j.1600-6143.2003.00079.x.

DOI:10.1034/j.1600-6143.2003.00079.x

PMID:12752309

Abstract

摘要

相似文献

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

Am J Transplant. 2003 May;3(5):534-42. doi: 10.1034/j.1600-6143.2003.00079.x.

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.

Clin Biochem. 2001 Feb;34(1):17-22. doi: 10.1016/s0009-9120(00)00184-3.

The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.

Br J Clin Pharmacol. 2017 Apr;83(4):812-822. doi: 10.1111/bcp.13154. Epub 2016 Nov 30.

Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.

Br J Clin Pharmacol. 2014 Nov;78(5):1102-12. doi: 10.1111/bcp.12426.

Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.

Transplant Proc. 2001 May;33(3):2170-1. doi: 10.1016/s0041-1345(01)02064-4.

Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.

J Clin Pharmacol. 2007 Jul;47(7):850-9. doi: 10.1177/0091270007301624. Epub 2007 May 25.

[A new immunosuppressor: CellCept].

Presse Med. 2001 Jan 20;30(2):66-7.

Monitoring of mycophenolic acid in clinical transplantation.

Ther Drug Monit. 2002 Feb;24(1):68-73. doi: 10.1097/00007691-200202000-00012.

IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.

Clin Chem. 1997 Dec;43(12):2312-7.

Mycophenolate mofetil: a report of the consensus panel.

Ther Drug Monit. 1995 Dec;17(6):690-9. doi: 10.1097/00007691-199512000-00025.

引用本文的文献

Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients.

Microbiome. 2025 Jul 24;13(1):169. doi: 10.1186/s40168-025-02142-6.

Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration-Time Curve in Steroid-Free Kidney Transplant Patients.

Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70056. doi: 10.1111/bcpt.70056.

Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors.

Pharmaceuticals (Basel). 2025 Feb 20;18(3):283. doi: 10.3390/ph18030283.

mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others.

Front Pharmacol. 2024 Aug 26;15:1443794. doi: 10.3389/fphar.2024.1443794. eCollection 2024.

Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps.

J Clin Med. 2024 Jan 13;13(2):451. doi: 10.3390/jcm13020451.

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing.

Biomedicines. 2022 Nov 10;10(11):2882. doi: 10.3390/biomedicines10112882.

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation.

Front Pharmacol. 2022 Oct 13;13:1002628. doi: 10.3389/fphar.2022.1002628. eCollection 2022.

Drug monitoring in systemic lupus erythematosus.

Curr Opin Pharmacol. 2022 Jun;64:102225. doi: 10.1016/j.coph.2022.102225. Epub 2022 Apr 28.

Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study.

J Scleroderma Relat Disord. 2021 Feb;6(1):87-95. doi: 10.1177/2397198320944342. Epub 2020 Aug 6.

Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients.

Clin Drug Investig. 2022 Mar;42(3):207-219. doi: 10.1007/s40261-022-01121-1. Epub 2022 Feb 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

作者信息

Shaw Leslie M, Korecka Magdalena, Venkataramanan Raman, Goldberg Lee, Bloom Roy, Brayman Kenneth L

机构信息

Department of Pathology & Laboratory Medicine, School of Pharmacy, University of Pittsburgh, PA 15261, USA.

出版信息

Am J Transplant. 2003 May;3(5):534-42. doi: 10.1034/j.1600-6143.2003.00079.x.

DOI:10.1034/j.1600-6143.2003.00079.x

PMID:12752309

Abstract

摘要

相似文献

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

Am J Transplant. 2003 May;3(5):534-42. doi: 10.1034/j.1600-6143.2003.00079.x.

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.

Clin Biochem. 2001 Feb;34(1):17-22. doi: 10.1016/s0009-9120(00)00184-3.

The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.

Br J Clin Pharmacol. 2017 Apr;83(4):812-822. doi: 10.1111/bcp.13154. Epub 2016 Nov 30.

Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.

Br J Clin Pharmacol. 2014 Nov;78(5):1102-12. doi: 10.1111/bcp.12426.

Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.

Transplant Proc. 2001 May;33(3):2170-1. doi: 10.1016/s0041-1345(01)02064-4.

Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.

J Clin Pharmacol. 2007 Jul;47(7):850-9. doi: 10.1177/0091270007301624. Epub 2007 May 25.

[A new immunosuppressor: CellCept].

Presse Med. 2001 Jan 20;30(2):66-7.

Monitoring of mycophenolic acid in clinical transplantation.

Ther Drug Monit. 2002 Feb;24(1):68-73. doi: 10.1097/00007691-200202000-00012.

IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.

Clin Chem. 1997 Dec;43(12):2312-7.

Mycophenolate mofetil: a report of the consensus panel.

Ther Drug Monit. 1995 Dec;17(6):690-9. doi: 10.1097/00007691-199512000-00025.

引用本文的文献

Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients.

Microbiome. 2025 Jul 24;13(1):169. doi: 10.1186/s40168-025-02142-6.

Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration-Time Curve in Steroid-Free Kidney Transplant Patients.

Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70056. doi: 10.1111/bcpt.70056.

Dengue Virus Inhibitors as Potential Broad-Spectrum Flavivirus Inhibitors.

Pharmaceuticals (Basel). 2025 Feb 20;18(3):283. doi: 10.3390/ph18030283.

mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others.

Front Pharmacol. 2024 Aug 26;15:1443794. doi: 10.3389/fphar.2024.1443794. eCollection 2024.

Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps.

J Clin Med. 2024 Jan 13;13(2):451. doi: 10.3390/jcm13020451.

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing.

Biomedicines. 2022 Nov 10;10(11):2882. doi: 10.3390/biomedicines10112882.

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation.

Front Pharmacol. 2022 Oct 13;13:1002628. doi: 10.3389/fphar.2022.1002628. eCollection 2022.

Drug monitoring in systemic lupus erythematosus.

Curr Opin Pharmacol. 2022 Jun;64:102225. doi: 10.1016/j.coph.2022.102225. Epub 2022 Apr 28.

Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study.

J Scleroderma Relat Disord. 2021 Feb;6(1):87-95. doi: 10.1177/2397198320944342. Epub 2020 Aug 6.

Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients.

Clin Drug Investig. 2022 Mar;42(3):207-219. doi: 10.1007/s40261-022-01121-1. Epub 2022 Feb 18.